Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: The Pan-Asia Menopause (PAM) study

Climacteric

Volumn 9, Issue 3, 2006, Pages 204-214

  Limpaphayom, K K ^a   Darmasetiawan, ^b   Hussain, R I ^c   Burriss, S W ^d   Holinka, C F ^e   Ausmanas, M K ^d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Gatot Soebroto Hospital   (Indonesia)

^c ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

^d PFIZER INC   (United States)

^e PharmConsult   (United States)

Author keywords

Asian women; Hormone therapy; Menopause; MENQOL; PAM study; Pan Asia Menopause study; Quality of life

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO;

ADRENERGIC SYSTEM; ARTICLE; ASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ETHNIC GROUP; FEMALE; HORMONAL THERAPY; HUMAN; INDONESIA; MALAYSIA; MENOPAUSE; MULTICENTER STUDY; PAKISTAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SOCIAL PSYCHOLOGY; TAIWAN; THAILAND; TREATMENT OUTCOME; VIET NAM;

ADULT; AGED; DOUBLE-BLIND METHOD; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HEALTH SURVEYS; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33646708512     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130600722520     Document Type: Article

References (34)

1. Bäckström T, Andreen L, Birzniece V, et al. The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003;17:325-42
2. Dickerson LM, Mazyck PAJ, Hunter MH. Premenstrual syndrome. Am Fam Physician 2003;67:1743-52
3. Robertson E, Grace S, Wallington T, Stewart DE. Antenatal risk for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiat 2004;26:289-95
4. Sherwin BB. Impact of the changing hormonal milieu on psychologic functioning. In Lobo RA, ed. Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. Philadelphia: Lippincott Williams & Wilkins, 1999:179-87
5. Blumel JE, Castelo-Branco C, Binfa L et al. Quality of life and the menopause: a population study. Maturitas 2000;34:17-23
6. Guthrie JR, Dennerstein L, Taffe JR, Lehert P, Burger HG. The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project. Climacteric 2004;7:375-89
7. Schneider HPG. Hormone Replacement Therapy and Quality of Life. Lancaster, UK. Parthenon Publishing, 2002:9-144
8. Haines CJ, Yim SF, Chung TKH, et al. A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women. Maturitas 2003;44:207-14
9. Tan D, Haines CJ, Limpaphayom KK, Holinka CF, Ausmanas MK. Relief of vasomotor symptoms and vaginal atrophy with three doses of conjugated estrogens and medroxyprogesterone acetate in postmenopausal Asian women from 11 countries: The Pan-Asia Menopause (PAM) Study. Maturitas 2005;52:35-51
10. Haines CJ, Xing S-M, Park K-H, Holinka CF, Ausmanas MK. Prevalence of menopausal symptoms in different ethnic groups of Asian women and responsiveness to three doses of conjugated estrogens/medroxyprogesterone acetate: The Pan-Asia Menopause (PAM) study. Maturitas 2005;52:264-76
11. Hilditch JR, Lewis J, Peter A, et al. A menopause-specific quality of life questionnaire: development and psychometric properties. Maturitas 1996;24:161-75
12. Obermeyer CM. Menopause across cultures: a review of the evidence. Menopause 2000;7:184-92
13. Hilditch JR, Chen S, Norton PG, Lewis J. Experience of menopausal symptoms by Chinese and Canadian women. Climacteric 1999;2:164-73
14. Fu S-Y, Anderson D, Courtney M. Cross-cultural menopausal experience: comparison of Australian and Taiwanese women. Nurs Health Sci 2003:5:77-84
15. Hunter MS. Predictors of menopausal symptoms: psychosocial aspects. Baillière's Clin Endocrinol Metab 1993;7:33-45
16. Sueblinvong T, Taechakraichana N, Phupong V. Prevalence of climacteric symptoms according to years after menopause. J Med Assoc Thai 2001;84:1681-91
17. Gelfand MM, Moreau M, Ayotte NJ, Hilditch JR, Wong BA, Lau CY. Clinical assessment and quality of life of postmenopausal women treated with a new intermittent progestogen combination hormone replacement therapy: a placebo-controlled study. Menopause 2003;10:29-36
18. Utian WH, Janata JW, Kingsberg SA, Schluchter M, Hamilton JC. The Utian Quality of Life (UQOL) Scale: development and validation of an instrument to quantify quality of life through and beyond menopause. Menopause 2002;9:402-10
19. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29:25-31
20. Schneider HPG, Rosemeier HP, Schnitker J, Gerbsch S, Turck R. Application and factor analysis of the menopause rating scale [MRS] in a post-marketing surveillance study. Maturitas 2000;37:113-24
21. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005;50:209-21
22. Hilditch JR, Lewis J, Ross AH, et al. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17β combined with an oral progestin on quality of life in postmenopausal women. Maturitas 1996;24:177-84
23. Chang C, Chang CH. Menopause and hormone using experiences of Chinese women in Taiwan. Health Care Women Int 1996;17:307-18
24. Lee KH. Korean urban women's experience of menopause: new life. Health Care Women Int 1997;18:139-48
25. Lam PM, Leung TN, Haines C, Chung TKH. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years. Maturitas 2003;45:99-107
26. Punyahotra S, Dennerstein L, Lehert P. Menopausal experiences of Thai women. 1. Symptoms and their correlates. Maturitas 1997;26:1-7
27. Zhao G, Wang L, Yan R, Dennerstein L. Menopausal symptoms: experience of Chinese women. Climacteric 2000;3:135-44
28. Wasti S, Robinson SC, Akhtar Y, Khan S, Badaruddin N. Characteristics of menopause in three socioeconomic urban groups in Karachi, Pakistan. Maturitas 1993;16:61-9
29. Chen Y-LD, Voda AM, Mansfield PK. Chinese midlife women's perceptions and attitudes about menopause. Menopause 1998;5:28-34
30. Lock M. Menopause in cultural context. Exp Gerontol 1994;29:307-17
31. Ismael NN. A study on the menopause in Malaysia. Maturitas 1994;19:205-9
32. Martin MC, Block JE, Sanchez SD, Arnaud CD, Beyene Y. Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993;168:1839-45
33. von Holst T, Salbach B. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints. Maturitas 2000;34:143-53
34. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 2001;75:1065-79